ArticleMolecular cancer2014

HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.

Eva Juengel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.